Provided by Tiger Trade Technology Pte. Ltd.

Kura Oncology

10.18
-0.4500-4.23%
Post-market: 10.14-0.0400-0.39%17:39 EST
Volume:2.70M
Turnover:27.51M
Market Cap:885.84M
PE:-4.10
High:10.72
Open:10.61
Low:10.03
Close:10.63
52wk High:12.49
52wk Low:5.41
Shares:87.02M
Float Shares:63.99M
Volume Ratio:1.81
T/O Rate:4.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4801
EPS(LYR):-2.0193
ROE:-65.10%
ROA:-26.57%
PB:3.65
PE(LYR):-5.04

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Cipher Mining, Kura, GrafTech

Reuters
·
Oct 24

Kura Oncology Receives $30M Milestone Payment

TIPRANKS
·
Oct 24

Kura Oncology Receives $30 Million Milestone Payment for Ziftomenib AML Program

Reuters
·
Oct 24

Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib Aml Program With Kyowa Kirin

THOMSON REUTERS
·
Oct 24

Kura Oncology Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 20

Kura Oncology announces preliminary data from FTI programs

TIPRANKS
·
Oct 20

Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Kura Oncology (KURA)

TIPRANKS
·
Oct 20

Kura Oncology Reports Promising Early Results for Darlifarnib in Combination Cancer Therapy

Reuters
·
Oct 18

Leerink Partners Reaffirms Their Buy Rating on Kura Oncology (KURA)

TIPRANKS
·
Oct 14

Bank of America Securities Keeps Their Buy Rating on Kura Oncology (KURA)

TIPRANKS
·
Oct 13

BRIEF-Kura Oncology Reports Inducement Grants

Reuters
·
Oct 03

Kura Oncology reports inducement grants under Nasdaq listing rule

TIPRANKS
·
Oct 03

Kura Oncology Grants Stock Options to New Employees Under 2023 Inducement Plan

Reuters
·
Oct 03

Kura Oncology, Kyowa Kirin doses first patient of KOMET-007 trial

TIPRANKS
·
Oct 01

Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of Npm1 and Flt3 Mutations in Patients With Newly Diagnosed Acute Myeloid Leukemia (Aml)

THOMSON REUTERS
·
Oct 01

Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

GlobeNewswire
·
Oct 01

Kura Oncology (KURA) Gets a Buy from Citizens JMP

TIPRANKS
·
Sep 30

Kura Oncology Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 30

Kura Oncology Executives Cash In: Massive Stock Sales Unveiled!

TIPRANKS
·
Sep 30

Kura Oncology COO Kathleen Ford Reports Disposal of Common Shares

Reuters
·
Sep 30